Loading...
Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models
BACKGROUND: Signaling through mTOR and somatostatin pathway is implicated in thyroid cancer development. METHOD: We evaluated everolimus, an mTOR inhibitor and pasireotide, a multi receptor somatostatin analogue as potential therapy of thyroid cancer focusing on the in vitro and in vivo efficacy, as...
Na minha lista:
| Udgivet i: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6390992/ https://ncbi.nlm.nih.gov/pubmed/30807575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206309 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|